,33 To examine the anti-HCC effect of miR-22, RAS/AKT-induced HCC female mice were treated with either AAV8-miR-22 (miR-22 treated) or AAV8 control (untreated). This evidence concerns the gene AKT1 and hepatocellular carcinoma.